Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof
US-2024390298-A1 · Nov 28, 2024 · US
Treatment of central nervous system disorders
US8940902B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8940902-B2 |
| Application number | US-201213554698-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 20, 2012 |
| Priority date | Apr 7, 2006 |
| Publication date | Jan 27, 2015 |
| Grant date | Jan 27, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition comprising a compound of formula (IV) wherein: n is 2; R 1 is each of which is independently unsubstituted or substituted with 1 or 2 substituents independently selected from the group co…
Assignees
- Bitner R Scott
- Browman Kaitlin E
- Brune Michael E
- Chen Yixian
- Dinges Jurgen
- Drescher Karla
- Jacobson Peer
- Jae Hwan-Soo
- Kurukulasuriya Ravi
- Link James T
- Madar David J
- Patel Jyoti R
- Pliushchev Marina A
- Rohde Jeffrey J
- Rueter Lynne E
- Shuai Qi
- Sorensen Bryan K
- Wang Jiahong
- Wicke Karsten M
- Winn Martin
- Wodka Dariusz
- Yeh Vince
- Yong Hong
- Abbvie Inc
Inventors
- Bitner R Scott
- Browman Kaitlin E
- Brune Michael E
- Chen Yixian
- Dinges Jurgen
- Drescher Karla
- Jacobson Peer
- Jae Hwan-Soo
- Kurukulasuriya Ravi
- Link James T
- Madar David J
- Patel Jyoti R
- Pliushchev Marina A
- Rohde Jeffrey J
- Rueter Lynne E
- Shuai Qi
- Sorensen Bryan K
- Wang Jiahong
- Wicke Karsten M
- Winn Martin
- Wodka Dariusz
- Yeh Vince
- Yong Hong
Classifications
Human Necessities · mapped topic
- A61K31/44Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8940902B2 cover?
- A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizop…
- Who is the assignee on this patent?
- Bitner R Scott, Browman Kaitlin E, Brune Michael E, and 21 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/44. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).